Literature DB >> 23409769

Early growth response gene-1 and hypoxia-inducible factor-1α affect tumor metastasis via regulation of tissue factor.

Li Sun1, Yang Liu, Sensen Lin, Jing Shang, Jin Liu, Ji Li, Shengtao Yuan, Luyong Zhang.   

Abstract

BACKGROUND: Hypoxia up-regulated expression of tissue factor (TF) may facilitate tumor cell metastasis, but transcriptional mechanisms remain undefined.
MATERIAL AND METHODS: To verify the role of Egr-1 in hypoxia-induced TF expression in breast cancer cells, quantitative PCR and Western blot analysis were performed. The secretion of VEGF under hypoxia was detected by enzyme-linked immunosorbent assay (ELISA). Egr-1 and HIF-1α siRNA were transiently transfected into breast cancer cells to evaluate their specific roles.
RESULTS: The increased Egr-1 expression occurring in hypoxic breast cancer cells can up-regulate TF expression and stimulating protein 1(Sp1) was not responsible for the hypoxia-induced expression of TF. HIF-1α mediated the hypoxia-induced up-regulation of TF expression through vascular endothelial growth factor (VEGF). The regulatory effects of Egr-1 on TF under hypoxia were independent of HIF-1α. Either Egr-1 or HIF-1α was responsible for hypoxic induction of tumor cells adhesion. HIF-1α, but not Egr-1, had a pivotal role in human breast cancer cells invasion. Both Egr-1 and HIF-1α were critical to angiogenesis induced by hypoxic conditions in MDA-MB-231 and HUVEC co-cultures. In nude mice, both Egr-1 and HIF-1α small interfering RNA (siRNA) could decrease extravasation of MDA-MB-435 cells in the lung after tail vein injection.
CONCLUSIONS: Hypoxia-induced expression of TF in human breast cancer cells depends on Egr-1 and HIF-1α, and both of these proteins may play an important role in breast cancer metastasis, either directly or indirectly through the TF pathway.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23409769     DOI: 10.3109/0284186X.2013.705890

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  8 in total

Review 1.  Tissue Factor and Cancer: Regulation, Tumor Growth, and Metastasis.

Authors:  Yohei Hisada; Nigel Mackman
Journal:  Semin Thromb Hemost       Date:  2019-05-16       Impact factor: 4.180

Review 2.  Tissue factor: a neglected role in cancer biology.

Authors:  Haiyuan Li; Yang Yu; Lei Gao; Peng Zheng; Xiaolong Liu; Hao Chen
Journal:  J Thromb Thrombolysis       Date:  2022-06-28       Impact factor: 2.300

Review 3.  Beyond thrombosis: the impact of tissue factor signaling in cancer.

Authors:  Dusten Unruh; Craig Horbinski
Journal:  J Hematol Oncol       Date:  2020-07-14       Impact factor: 17.388

Review 4.  Re-evaluation of hematocrit as a determinant of thrombotic risk in erythrocytosis.

Authors:  Victor R Gordeuk; Nigel S Key; Josef T Prchal
Journal:  Haematologica       Date:  2019-03-14       Impact factor: 9.941

5.  Oct4 upregulates osteopontin via Egr1 and is associated with poor outcome in human lung cancer.

Authors:  Yin-Hsun Feng; Yu-Chu Su; Shuo-Fu Lin; Pey-Ru Lin; Chao-Liang Wu; Chao-Ling Tung; Chien-Feng Li; Gia-Shing Shieh; Ai-Li Shiau
Journal:  BMC Cancer       Date:  2019-08-09       Impact factor: 4.430

6.  Multiphysics and multiscale modeling of microthrombosis in COVID-19.

Authors:  He Li; Yixiang Deng; Zhen Li; Ander Dorken Gallastegi; Christos S Mantzoros; Galit H Frydman; George E Karniadakis
Journal:  PLoS Comput Biol       Date:  2022-03-07       Impact factor: 4.779

7.  EPCR-PAR1 biased signaling regulates perfusion recovery and neovascularization in peripheral ischemia.

Authors:  Magdalena L Bochenek; Rajinikanth Gogiraju; Stefanie Großmann; Janina Krug; Jennifer Orth; Sabine Reyda; George S Georgiadis; Henri M Spronk; Stavros Konstantinides; Thomas Münzel; John H Griffin; Philipp Wild; Christine Espinola-Klein; Wolfram Ruf; Katrin Schäfer
Journal:  JCI Insight       Date:  2022-07-22

Review 8.  Tissue factor in tumor microenvironment: a systematic review.

Authors:  Xiao Han; Bo Guo; Yongsheng Li; Bo Zhu
Journal:  J Hematol Oncol       Date:  2014-08-01       Impact factor: 17.388

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.